Drug Eluting Stents versus Bare Metal Stents for Cardiac Allograft Vasculopathy: A Systematic Review and Meta-Analysis
Cardiac allograft vasculopathy (CAV) is one of the leading causes of late mortality among heart transplant recipients. Retransplantation, although considered the only definitive therapy, is not a feasible option for most patients. Percutaneous coronary intervention (PCI) with drug eluting stents (DES) or bare metal stents (BMS) has become a palliative, more accessible therapy. We conducted a systematic review and meta-analysis to investigate clinical outcomes of DES vs BMS.
Source: The Journal of Heart and Lung Transplantation - Category: Transplant Surgery Authors: J. Maning, V. Blumer, S. Chaparro Tags: (556) Source Type: research
More News: Angioplasty | Bone Graft | Cardiology | Coronary Angioplasty | Heart | Heart Transplant | Lung Transplant | Palliative | Percutaneous Coronary Intervention | Transplant Surgery | Transplants